• Categories
  • Archives

Brazil Threatens to Break More Drugs Patents If Prices Don’t Go Down

Merck's anti-AIDS drug Stocrin (Efivarenz) Merck's anti-AIDS drug Stocrin (Efivarenz)

Merck's anti-AIDS drug Stocrin (Efivarenz) Right after signing the decree breaking the patent of Merck's anti-AIDS drug Efavirenz, Brazilian President Luiz Inácio Lula da Silva said that the same may happen to other medications, in the future. "Today it's being used for this medication, tomorrow it might be used for another one," threatened the president.

The compulsory licensing, as the Brazilian government calls the patent breaking, might occur every time prices are "far from the Brazilian reality…. If the prices are not fair; not only for us, but for every human being infected on this planet we will have to make this decision."

Lula was warmly applauded when he declared to a crowd of AIDS patients and employees from the Health Ministry: "It is not right that anyone gets rich with the misfortune of others."

"Not only this is something rude from the ethical point of view, but it's also a disrespect from the political-economical point of view." And he completed by saying: "Having to choose between our trade and our health, we will take care of our health… We will not give up taking care of our people and we wish to take care of our companions with AIDS."

Lula has authorized Brazil to break the patent on Efavirenz importing a generic version from India instead. It's the first time Brazil has bypassed a patent to acquire cheaper drugs for its AIDS prevention program.

Merck said it was "profoundly disappointed" after talks over the drug's price broke down. Merck had offered a 30% cut on its 1.59 per pill price. Brazil's health ministry wanted to pay what Merck charges Thailand 65 US cents per pill, another country to negate World Health Organization rules on drug patents in the name of public health.

Brazil's government offers free access to AIDS' drugs condoms and syringes, a move that has helped stabilize infection rates at around 0.6% in adults – the same level as in the United States.

"Merck is profoundly disappointed by the decision of the Government of Brazil to issue a compulsory license for Stocrin (Efavirenz), which would break Merck & Co Inc.'s patent and make it possible for Efavirenz to be produced by a generic manufacturer", said the company in an official release.

"Merck has attempted to negotiate in good faith with Brazil, but a fair offer on Stocrin has been rejected. While we remain flexible and committed to exploring a mutually acceptable agreement with the Brazilian government to help the country achieve its objective of universal access to treatment, we believe their action is not in the best interests of patients in Brazil and around the world."

Further on it states that "this expropriation of intellectual property sends a chilling signal to research-based companies about the attractiveness of undertaking risky research on diseases that affect the developing world, potentially hurting patients who may require new and innovative life-saving therapies."

Brazil will not proceed to import the generic version from three laboratories in India, certified by WHO, saving an estimated US$ 30 million annually, said Health minister José Gomes Temporão.

"We will be paying Merck 1.5% royalty on the price of the generic version imported from India".

Brazil argues its decision is protected by the 2001 Trips agreement in the framework of the World Trade Organization which enables developing countries to privilege public health over intellectual property.

Bzz, Mercopress

Tags:

  • Show Comments (2)

  • AES

    I hope Brazil’s knowledge of international law ie the Trips Agreement, is equal to the potentially dileterious effect that usurpation of capital property rights is perceived by Western invstors as a kind of intellectual piracy. I would be curous this morning how Bovespa responds to this Bolivian style nationalization for the good of the people, ie the State, as opposed to the Law. Thirty million is comparatively small change to jeopardize the billions being traded at this time. The road to economic hell is paved with good intentions.
    Honor to contract is fundamental to global confidence in a market. The 30 percent reduction offered by Merk is significant. And Thailand is an infinitely poorer country than Brazil whose origins are neolithic. There is little comparison betwen Thailand and Brazil economicaly. Brizil’s potential is on a par with Canada. Clean water and sewage would affect many more Brazilians lives than Merk’s drugs. The security of investment is a matter of perception, and the endorsement of what amounts to the piracy of intellectual property will not bode well in the perception of golbal Banking and Investment firsms.

  • bo

    It’s not that simple…
    to just say, “these drugs are overpriced”. People and governments have to realize that most of these big pharm’s invest billions every year on R&D and because of this we continue to get better medications and cures. If all countries did what Brazil is doing the pharm’s would go belly up or would no longer be able to invest what they do today in R&D and then we could give up on the hope of ever finding cures for other debilitating diseases.

Your email address will not be published. Required fields are marked *

comment *

  • name *

  • email *

  • website *

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Ads

You May Also Like

The Beast in on the Loose in Brazil’s Backlands

The beast was bored. The very-strong sun was hitting his head and leaving him ...

Lula's brother, Genival Inácio da Silva

Brazil’s First Brother Caught in Police’s Latest Anti-Corruption Operation

Among the catches of Operation Checkmate, Brazilian Federal Police's latest anticorruption raid, was Brazil ...

Morocco and Brazil Find Out They Are Open for Business

The search for partnerships with Brazilian companies was one of the main objectives of ...

Brazil to Slow Growth Pace Now

Brazilian markets rose, as investors reacted positively to an in-line interest rate hike in ...

Led by Brazil Mercosur’s Exports Grow 20% and Imports 18%

Imports of goods by Africa and the Middle East grew 18% in nominal terms ...

Is Brazil’s Seleçí£o Becoming Complacent?

There are confident supporters of Brazil, who rationalize that Brazil has yet to play ...

In Brazil the Press Doesn’t Get Any Respect

Two reporters from the comedy show CQC (Custe o que Custar – Whatever the ...

Brazil Markets Start Week in Upbeat Mood

Latin American equities jumped on the session, led by strong advances from Brazil and ...

A Backlands Hit

The most innovative part of the Ceará story is not the budget cuts but ...

Child Labor Seen as Good for Country and Kids by Brazilians

The International Labor Organization’s (ILO) projects coordinator, Renato Mendes, believes that child labor is ...